Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
- Chamber
- House
- Introduced
- Mar 25, 2025
- Last action
- Jan 7, 2026 — REFERRED TO HEALTH
- Session
- 2025-2026
- Momentum
- 27 · Low